Program Overview Update: Funds for this program have been exhausted through the first two rounds of proposals and it is currently no longer taking proposals. Thank you for all the wonderful ideas and proposals that have been submitted! In response to the unprecedented research challenges presented by the COVID-19 pandemic, UC Davis Office of Research is launching […]
By Lisa Howard The Office of Research has launched a COVID-19 Research Working Group to help faculty, postdocs and students connect with collaborators and funding opportunities. A website, Slack channel, Sympa email list and curated list of funding opportunities have been set up. There are also weekly teleconferences. While non-critical on-site research activities have been ramped down on campus, critical research, which includes COVID-19 research […]
A Message from Vice Chancellor for Research Prasant Mohapatra to the UC Davis Research Community I am writing to provide guidance for managing research activities during the COVID-19 pandemic. UC Davis remains open for research activities at this point in time, but we strongly recommend that on-campus research activities be adjusted and reduced where […]
By Lisa Howard UC Davis medical and engineering experts are teaming up to develop an under-clothing biosensor that can recognize in real time when someone’s bladder is full. Most people take that kind of biological awareness for granted, but it is lacking for the approximately half a million individuals in the United States with spinal […]
Sierra Biopharma, a biotechnology startup founded on intellectual property developed by researchers at the University of California, Davis, is developing a new therapeutic approach to treat autoimmune diseases. Inventors and co-founders Robert Fairclough and Vu Trinh have set an initial focus on treating myasthenia gravis, a chronic autoimmune disease that affects 1.4 million people globally. […]
As the Mouse Biology Program (MBP) begins its third decade of service as a scientific resource for campus researchers, we are pleased to announce that effective March 1st they will join the UC Davis Office of Research. With operational and administrative oversight provided by the Office of Research, this move will place MBP in a better position […]
By Lisa Howard PvP Biologics, a startup formed around technology developed at the University of Washington and the University of California, Davis, announced on February 26 that it has been acquired by Takeda Pharmaceutical Company Limited. The acquisition comes after the conclusion of a Phase 1 proof-of-mechanism study of an investigational medicine, TAK-062, also known as Kuma062, […]
